the total amount paid out in life claims was £129.4m, with £13.46m paid in terminal illness claims..

"we were quite surprised to find there were no significant differences," says study author..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..: "fremanezumab for the preventive treatment of chronic migraine.".

his heart, beating for 84 years and full of love for the woman he affectionately called his "blue-eyed guera [pronounced whedda]," felt like it was failing..